Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Change in Account Payables (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Change in Account Payables for 10 consecutive years, with -$124000.0 as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 118.13% to -$124000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $350000.0 through Dec 2025, up 136.69% year-over-year, with the annual reading at $350000.0 for FY2025, 136.69% up from the prior year.
  • Change in Account Payables hit -$124000.0 in Q4 2025 for STRATA Skin Sciences, down from $9000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.1 million in Q1 2022 to a low of -$1.2 million in Q3 2024.
  • Historically, Change in Account Payables has averaged -$2150.0 across 5 years, with a median of $115500.0 in 2022.
  • Biggest five-year swings in Change in Account Payables: plummeted 583.59% in 2023 and later surged 307.14% in 2024.
  • Year by year, Change in Account Payables stood at $342000.0 in 2021, then plummeted by 376.02% to -$944000.0 in 2022, then surged by 117.8% to $168000.0 in 2023, then skyrocketed by 307.14% to $684000.0 in 2024, then tumbled by 118.13% to -$124000.0 in 2025.
  • Business Quant data shows Change in Account Payables for SSKN at -$124000.0 in Q4 2025, $9000.0 in Q3 2025, and $103000.0 in Q2 2025.